Syndax Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.About SNDX
Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES.
CEOMichael A. Metzger
CEOMichael A. Metzger
Employees270
Employees270
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2005
Founded2005
Employees270
Employees270
SNDX Key Statistics
Market cap1.72B
Market cap1.72B
Price-Earnings ratio-5.46
Price-Earnings ratio-5.46
Dividend yield—
Dividend yield—
Average volume2.18M
Average volume2.18M
High today$20.02
High today$20.02
Low today$19.31
Low today$19.31
Open price$19.55
Open price$19.55
Volume1.46M
Volume1.46M
52 Week high$20.20
52 Week high$20.20
52 Week low$8.58
52 Week low$8.58
Stock Snapshot
With a market cap of 1.72B, Syndax Pharmaceuticals(SNDX) trades at $19.74. The stock has a price-to-earnings ratio of -5.46.
During the trading session on 2025-12-04, Syndax Pharmaceuticals(SNDX) shares reached a daily high of $20.02 and a low of $19.31. At a current price of $19.74, the stock is +2.2% higher than the low and still -1.4% under the high.
Trading volume for Syndax Pharmaceuticals(SNDX) stock has reached 1.46M, versus its average volume of 2.18M.
Over the past 52 weeks, Syndax Pharmaceuticals(SNDX) stock has traded between a high of $20.20 and a low of $8.58.
Over the past 52 weeks, Syndax Pharmaceuticals(SNDX) stock has traded between a high of $20.20 and a low of $8.58.
Analyst ratings
100%
of 14 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SNDX. This list is generated using Robinhood data, and it’s not a recommendation.